Functional importance of mTOR signalling has been experimentally confirmed in Alzheimer’s disease, and therapeutic targeting of this signalling module is considered as a promising strategy for developing neuro-protective treatments [59–61]. This evidence concerns the gene MTOR and early-onset autosomal dominant Alzheimer disease.